Electrophysiology Market by Product EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices, Indication Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, WolffParkinsonWhite Syndrome Global Opp

21:41 EDT 30 Jul 2017 | BioPortfolio Report Blog

Electrophysiology EP is the branch of science that deals with the study of electric activity in the human body. EP devices are used to treat abnormal electrical properties of cell and tissues that leads to various cardiac arrhythmias. Innovative EP technologies are developed to improve the diagnosis and treatment of lifethreatening conditions, such as atrial fibrillation AF, atrial flutter, WolffParkinsonWhite Syndrome WPW, atrioventricular nodal reentry tachycardia AVNRT, and other cardiac arrhythmias.nnThe growing incidence of AFone of the most common heart rhythm disorder or arrhythmia is the prime factor to drive the growth of the EP market. In addition, cardiovascular diseases treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Increase in baby boomer generation with highrisk of targeted diseases and increase in adoption of EP catheter ablation propels the market growth. Moreover, rise in focus of the key players toward innovative EP technologies such as 3D mapping systems, novel diagnostic catheters, and laser ablation systems, has fuel the demand for EP devices across various settings in EP labs. However, stringent government regulations, high cost of the advanced EP devices, preference to pharmaceutical interventions drugs over EP treatment devices and dearth of skilled amp; experienced electrophysiologists are set to restrain the market growth. The world electrophysiology market is projected reach $8,271 Million by 2022, growing at a CAGR of 13.4% during 2016 to 2022, from 2015 market value of $3,420 million.nnThe world electrophysiology market is segmented on the basis of product, indication and geography. Based on product, the market is segmented primarily into EP ablation catheters, EP laboratory devices, EP diagnostic catheters, access devices and others. EP ablation catheter is further subsegmented into cryoablation EP catheters, radiofrequency EP catheters, microwave EP catheters, laser EP catheters, and navigational advanced mapping accessories. Radiofrequency EP catheters are further categorized into conventional and irrigatedtip ablation catheters. Radiofrequency EP catheters has the largest market share, owing to high prevalence rate of atrial fibrillation and technological advancements in RF ablation such as irrigated tip catheters, which is found to be superior in terms of efficacy and safety than conventional RF ablation. Cryoablation EP catheter market is expected to grow at the fastest rate due to technological advancements in this sector and preferred option by the physicians to ablate abnormal cardiac cells, where procedural precision is crucial.nbsp; In addition, EP XRay Systems holds remarkable share in the EP market and poised to grow at steady pace due to the growing demand in EP labs to enhance the ability to perform complex procedures with confidence. Moreover, steerable diagnostic catheters are the driving force behind the growth of conventional EP diagnostic catheters attributed to the rising adoption of these devices gaining FDA approval for the treatment of AF. Based on indication, the market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia AVNRT, WolffParkinsonwhite syndrome WPW and others. Atrial fibrillation holds the highest share in the indication segment owing to the high incident rate and the most common type of cardiac arrhythmia in clinical practice. nbsp;nnThe geographical segmentation of the market includes North America, Europe, AsiaPacific, and LAMEA. In 2015, North America accounted for the largest market share of 36.2% in the EP market and estimated to retain its dominant position throughout the forecast period. The growth in this region is mainly due to the factors such as product innovations, sophisticated healthcare infrastructure, U.S. ndash; being the target area for the top players in the market owing to high prevalence rate of AF. Nevertheless, Asia Pacific region is expected to emerge as the area with maximum growth potential due to the rising number of cardiovascular diseases, presence of high unmet needs, and increased focus of key players towards emerging markets such as China and India, and increased healthcare spending for the development of improved healthcare infrastructure.nnProduct development and launch is the mostly adopted strategy in the electrophysiology market followed by acquisition. The report provides a comprehensive analysis of the key players that operate in the world Electrophysiology market such as:nnnnSt. Jude Medical, Inc.nnBoston Scientific Corporation,nnBiosense Webster, Inc. a Johnson amp; Johnson CompanynnMedtronic, Inc.nnSiemens AGnnGE Healthcare a division of General Electric Company.nnPhilips Healthcare a division of Koninklijke Philips N.V.nnBiotronik SE amp; Co.KGnnAbbott Laboratories.nnMicroport Scientific CorporationnnnKEY MARKET BENEFITSnnnnThe study provides an indepth analysis of the world electrophysiology market with current trends and future estimations to elucidate the imminent investment pockets.nnThe report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.nnExtensive analysis of the market, by product, helps understand various types of devices used for the treatment of atrial fibrillation, atrial flutter, WolffParkinsonWhite Syndrome, atrioventricular nodal reentry tachycardia, and other cardiac arrhythmias.nnCompetitive intelligence highlights the business practices followed by the leading market players across various geographies.nnPorterrsquo;s Five Forces model will interpret the bargaining power of suppliers and buyers, threat of new entrants and substitutes, and competition amongst the key players.nnnKEY MARKET SEGMENTSnnBy ProductnnnnEP Ablation CathetersnnnnnnCryoablation EP CathetersnnnRadiofrequency Ablation CathetersnnnnnnnIrrigatedtip Radiofrequency Ablation CathetersnnnnConventional Radiofrequency Ablation CathetersnnnnnnnnnMicrowave Ablation SystemsnnnLaser Ablation SystemsnnnNavigational Advanced Mapping AccessoriesnnnnnnEP Laboratory DevicesnnnnnEP XRay Systemsnnn3D Mapping SystemsnnnEP Recording SystemsnnnEP Remote Steering SystemsnnnOthersnnnnnnEP Diagnostic CathetersnnnnnConventional EP Diagnostic CathetersnnnnnnnSteerable Diagnostic CathetersnnnnFixed Diagnostic CathetersnnnnnnnnnAdvanced EP Diagnostic CathetersnnnUltrasound EP Diagnostic CathetersnnnnnnAccess DevicesnnOthersnnnBy IndicationnnnnAtrial Fibrillation AFnnAtrial FlutternnWolffParkinsonWhite Syndrome WPWnnAtrioventricular Nodal Reentry Tachycardia AVNRTnnOthersnnnBy GeographynnnnNorth AmericannnnnnU.S.nnnCanadannnMexiconnnnnnEuropennnnnU.K.nnnFrancennnGermanynnnItalynnnRest of EuropennnnnnAsiaPacificnnnnnJapannnnChinannnIndiannnAustraliannnRest of Asia PacificnnnnnnLAMEAnnnnnBrazilnnnArgentinannnEgyptnnnIsraelnnnSouth AfricannnRest of LAMEAnnnnn

Original Article: Electrophysiology Market by Product EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices, Indication Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, WolffParkinsonWhite Syndrome Global Opp


More From BioPortfolio on "Electrophysiology Market by Product EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices, Indication Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, WolffParkinsonWhite Syndrome Global Opp"

Quick Search

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...